A5000323140- COVID-19 Clinical Research Studies
- Inflammatory Bowel Disease
- Esophageal and GI Pathology
- Pancreatitis Pathology and Treatment
- Gastrointestinal disorders and treatments
- Long-Term Effects of COVID-19
- Gallbladder and Bile Duct Disorders
- Diverticular Disease and Complications
- Liver Disease Diagnosis and Treatment
- Microscopic Colitis
- SARS-CoV-2 and COVID-19 Research
- Gastrointestinal Bleeding Diagnosis and Treatment
- Gastroesophageal reflux and treatments
- Autoimmune and Inflammatory Disorders
- COVID-19 and healthcare impacts
- Appendicitis Diagnosis and Management
- Colorectal Cancer Surgical Treatments
- Liver Disease and Transplantation
- Biliary and Gastrointestinal Fistulas
- Gastrointestinal motility and disorders
- Eosinophilic Esophagitis
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Screening and Detection
- Abdominal vascular conditions and treatments
- Diagnosis and treatment of tuberculosis
The University of Texas Health Science Center at San Antonio
2021-2024
University Gastroenterology
2024
The University of Texas at San Antonio
2024
The University of Texas Health Science Center at Houston
2021-2024
Texas Tech University Health Sciences Center
2016-2023
Texas Tech University
2016-2023
Audie L. Murphy Memorial VA Hospital
2022
University of New Mexico
2022
University of Toledo
2020
Moses Taylor Hospital
2020
Gastrointestinal (GI) symptoms are increasingly being recognized in coronavirus disease 2019 (COVID-19). It is unclear if the presence of GI associated with poor outcomes COVID-19. We aim to assess could be used for prognostication hospitalized patients COVID-19.We retrospectively analyzed admitted a tertiary medical center Brooklyn, NY, from March 18, 2020, 31, The patients' charts were reviewed at admission, including nausea, vomiting, diarrhea, and abdominal pain. COVID-19 (cases)...
Introduction: Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing dramatic morbidity and mortality worldwide. The Red Blood Cell Distribution Width (RDW) has been strongly associated with increased in multiple diseases. Objective: To assess if elevated RDW unfavorable outcomes hospitalized COVID-19. Methods: We retrospectively studied clinical of COVID-19 patients for their values. In-hospital was defined as primary outcome,...
OBJECTIVES: Anastomotic reconstruction following intestinal resection in Crohn's disease (CD) may employ side-to-side anastomosis (STSA; anti-peristaltic orientation) or end-to-end (ETEA). Our aim was to determine the impact of these two anastomotic techniques on long-term clinical status postoperative CD patients. METHODS: We performed a comparative effectiveness study prospectively collected observational data from consented patients undergoing their first second ileocolonic bowel and...
Severe acute respiratory syndrome coronavirus-2 may escape the inactivation by gastric acid because of hypochlorhydria caused proton pump inhibitors (PPIs), which could predispose patients to severe COVID-19.We studied association between prehospitalization PPI exposure and clinical outcomes among hospitalized COVID-19 patients.A total 295 were included in study. 15.6% on PPIs at home. Mortality PPI-users was 2.3 times higher than non-users, along with risk distress after adjusting for...
Abstract Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2 infection, which evolved into a global pandemic within short time. Individuals with sickle cell (SCD) suffer from underlying cardiopulmonary comorbidities and are at risk of severe complications such as pneumonia, acute chest syndrome, thrombosis, stroke, multiorgan failure. Whether COVID‐19 poses high morbidity mortality in SCD patients remains unclear. Patients can present overlapping clinical features respiratory...